Anand Kolatkar

University of Southern California — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

33h-index3.2kcitations106works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(52), Cancer Cells and Metastasis(37), Prostate Cancer Treatment and Research(21), Glycosylation and Glycoproteins Research(14), Single-cell and spatial transcriptomics(12)

Publications106 total

Simultaneous expression of epithelial and immune cell markers in circulating tumor cells identified in patients with stage 4 breast cancer
Communications Medicine·2025· 3 citedOpen Access
Liquid Biopsy Profiling with Multiple Tests in Patients with Metastatic Breast Cancer
Journal of Molecular Pathology·2024· 3 citedOpen Access
Abstract 3560: Quantified kinematics and wearable sensors to predict serious adverse events in patients undergoing cancer therapy trials
Cancer Research·2024
Copper Isotope Fractionation and Copper-to-Zinc Ratios as Diagnostic Markers of Prostate Malignancy
2024Open Access
P2.08-06 A Phase II Study of Subcutaneous (SC) Atezolizumab in NSCLC Patients Using a Decentralized Clinical Trial Model
Journal of Thoracic Oncology·2023· 1 citedOpen Access
Cell State and Cell Type: Deconvoluting Circulating Tumor Cell Populations in Liquid Biopsies by Multi-Omics
Cancers·2023· 18 citedOpen Access
Abstract 2301: Copy number profiling of circulating CD45+/cytokeratin+ cells in a patient with metastatic breast cancer
Cancer Research·2023· 2 cited
Supplementary Figures 1-5 and Table S1 from Platelet-Coated Circulating Tumor Cells Are a Predictive Biomarker in Patients with Metastatic Castrate-Resistant Prostate Cancer
2023Open Access
Data from Platelet-Coated Circulating Tumor Cells Are a Predictive Biomarker in Patients with Metastatic Castrate-Resistant Prostate Cancer
2023Open Access
Data from Platelet-Coated Circulating Tumor Cells Are a Predictive Biomarker in Patients with Metastatic Castrate-Resistant Prostate Cancer
2023Open Access
Supplementary Figures 1-5 and Table S1 from Platelet-Coated Circulating Tumor Cells Are a Predictive Biomarker in Patients with Metastatic Castrate-Resistant Prostate Cancer
2023Open Access
Data from Single-Cell Circulating Tumor Cell Analysis Reveals Genomic Instability as a Distinctive Feature of Aggressive Prostate Cancer
2023Open Access
Supplementary Data from Single-Cell Circulating Tumor Cell Analysis Reveals Genomic Instability as a Distinctive Feature of Aggressive Prostate Cancer
2023Open Access
Data from Single-Cell Circulating Tumor Cell Analysis Reveals Genomic Instability as a Distinctive Feature of Aggressive Prostate Cancer
2023Open Access
Supplementary Data from Single-Cell Circulating Tumor Cell Analysis Reveals Genomic Instability as a Distinctive Feature of Aggressive Prostate Cancer
2023Open Access
Abstract P5-05-09: Multianalyte liquid biopsy to aid the diagnostic workup of breast cancer
Cancer Research·2023
Contrived Materials and a Data Set for the Evaluation of Liquid Biopsy Tests
Journal of Molecular Diagnostics·2023· 12 citedOpen Access
Multianalyte liquid biopsy to aid the diagnostic workup of breast cancer
npj Breast Cancer·2022· 23 citedOpen Access
Identification of epithelial and mesenchymal circulating tumor cells in clonal lineage of an aggressive prostate cancer case
npj Precision Oncology·2022· 34 citedOpen Access
Abstract 1957: Dissecting CTC phenotypic heterogeneity for predictive biomarker identification and its association with clonal lineage through single-cell multi-omic profiling
Cancer Research·2022
page 1 of 6Next →

Frequent Co-authors

Peter Kühn(42), Kelly Bethel(17), James Hicks(16), Madelyn Luttgen(15), Jorge J. Nieva(15), Carmen Ruiz Velasco(10), Jerry Lee(9), Lyudmila Bazhenova(7), Anders Carlsson(7), Dena Marrinucci(5), Amado J. Zurita(5), Mariam Rodrı́guez-Lee(5), Sean E. Hanlon(5), Lisa Welter(5), Stephanie N. Shishido(5), William I. Weis(4), Michael I. Recht(4), Rafael Nevarez(4), Robert L. Grossman(4), Paul K. Newton(4)